The Ras-Erk-ETS-signaling pathway is a drug target for longevity

Cathy Slack, Nazif Alic, Andrea Foley, Melissa Cabecinha, Matthew P. Hoddinott, Linda Partridge

Research output: Contribution to journalArticle

Abstract

Summary Identifying the molecular mechanisms that underlie aging and their pharmacological manipulation are key aims for improving lifelong human health. Here, we identify a critical role for Ras-Erk-ETS signaling in aging in Drosophila. We show that inhibition of Ras is sufficient for lifespan extension downstream of reduced insulin/IGF-1 (IIS) signaling. Moreover, direct reduction of Ras or Erk activity leads to increased lifespan. We identify the E-twenty six (ETS) transcriptional repressor, Anterior open (Aop), as central to lifespan extension caused by reduced IIS or Ras attenuation. Importantly, we demonstrate that adult-onset administration of the drug trametinib, a highly specific inhibitor of Ras-Erk-ETS signaling, can extend lifespan. This discovery of the Ras-Erk-ETS pathway as a pharmacological target for animal aging, together with the high degree of evolutionary conservation of the pathway, suggests that inhibition of Ras-Erk-ETS signaling may provide an effective target for anti-aging interventions in mammals. Video Abstract

LanguageEnglish
Pages72-83
Number of pages12
JournalCell
Volume162
Issue number1
Early online date25 Jun 2015
DOIs
Publication statusPublished - 2 Jul 2015

Fingerprint

Aging of materials
Pharmacology
Insulin-Like Growth Factor I
Pharmaceutical Preparations
Drosophila
Mammals
Insulin
Health
Conservation
Animals
trametinib

Bibliographical note

This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).

Cite this

Slack, C., Alic, N., Foley, A., Cabecinha, M., Hoddinott, M. P., & Partridge, L. (2015). The Ras-Erk-ETS-signaling pathway is a drug target for longevity. Cell, 162(1), 72-83. https://doi.org/10.1016/j.cell.2015.06.023
Slack, Cathy ; Alic, Nazif ; Foley, Andrea ; Cabecinha, Melissa ; Hoddinott, Matthew P. ; Partridge, Linda. / The Ras-Erk-ETS-signaling pathway is a drug target for longevity. In: Cell. 2015 ; Vol. 162, No. 1. pp. 72-83.
@article{837d46bd465b415a88340a2e858ce211,
title = "The Ras-Erk-ETS-signaling pathway is a drug target for longevity",
abstract = "Summary Identifying the molecular mechanisms that underlie aging and their pharmacological manipulation are key aims for improving lifelong human health. Here, we identify a critical role for Ras-Erk-ETS signaling in aging in Drosophila. We show that inhibition of Ras is sufficient for lifespan extension downstream of reduced insulin/IGF-1 (IIS) signaling. Moreover, direct reduction of Ras or Erk activity leads to increased lifespan. We identify the E-twenty six (ETS) transcriptional repressor, Anterior open (Aop), as central to lifespan extension caused by reduced IIS or Ras attenuation. Importantly, we demonstrate that adult-onset administration of the drug trametinib, a highly specific inhibitor of Ras-Erk-ETS signaling, can extend lifespan. This discovery of the Ras-Erk-ETS pathway as a pharmacological target for animal aging, together with the high degree of evolutionary conservation of the pathway, suggests that inhibition of Ras-Erk-ETS signaling may provide an effective target for anti-aging interventions in mammals. Video Abstract",
author = "Cathy Slack and Nazif Alic and Andrea Foley and Melissa Cabecinha and Hoddinott, {Matthew P.} and Linda Partridge",
note = "This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).",
year = "2015",
month = "7",
day = "2",
doi = "10.1016/j.cell.2015.06.023",
language = "English",
volume = "162",
pages = "72--83",
journal = "Cell",
issn = "0092-8674",
publisher = "Cell Press",
number = "1",

}

Slack, C, Alic, N, Foley, A, Cabecinha, M, Hoddinott, MP & Partridge, L 2015, 'The Ras-Erk-ETS-signaling pathway is a drug target for longevity' Cell, vol. 162, no. 1, pp. 72-83. https://doi.org/10.1016/j.cell.2015.06.023

The Ras-Erk-ETS-signaling pathway is a drug target for longevity. / Slack, Cathy; Alic, Nazif; Foley, Andrea; Cabecinha, Melissa; Hoddinott, Matthew P.; Partridge, Linda.

In: Cell, Vol. 162, No. 1, 02.07.2015, p. 72-83.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The Ras-Erk-ETS-signaling pathway is a drug target for longevity

AU - Slack, Cathy

AU - Alic, Nazif

AU - Foley, Andrea

AU - Cabecinha, Melissa

AU - Hoddinott, Matthew P.

AU - Partridge, Linda

N1 - This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).

PY - 2015/7/2

Y1 - 2015/7/2

N2 - Summary Identifying the molecular mechanisms that underlie aging and their pharmacological manipulation are key aims for improving lifelong human health. Here, we identify a critical role for Ras-Erk-ETS signaling in aging in Drosophila. We show that inhibition of Ras is sufficient for lifespan extension downstream of reduced insulin/IGF-1 (IIS) signaling. Moreover, direct reduction of Ras or Erk activity leads to increased lifespan. We identify the E-twenty six (ETS) transcriptional repressor, Anterior open (Aop), as central to lifespan extension caused by reduced IIS or Ras attenuation. Importantly, we demonstrate that adult-onset administration of the drug trametinib, a highly specific inhibitor of Ras-Erk-ETS signaling, can extend lifespan. This discovery of the Ras-Erk-ETS pathway as a pharmacological target for animal aging, together with the high degree of evolutionary conservation of the pathway, suggests that inhibition of Ras-Erk-ETS signaling may provide an effective target for anti-aging interventions in mammals. Video Abstract

AB - Summary Identifying the molecular mechanisms that underlie aging and their pharmacological manipulation are key aims for improving lifelong human health. Here, we identify a critical role for Ras-Erk-ETS signaling in aging in Drosophila. We show that inhibition of Ras is sufficient for lifespan extension downstream of reduced insulin/IGF-1 (IIS) signaling. Moreover, direct reduction of Ras or Erk activity leads to increased lifespan. We identify the E-twenty six (ETS) transcriptional repressor, Anterior open (Aop), as central to lifespan extension caused by reduced IIS or Ras attenuation. Importantly, we demonstrate that adult-onset administration of the drug trametinib, a highly specific inhibitor of Ras-Erk-ETS signaling, can extend lifespan. This discovery of the Ras-Erk-ETS pathway as a pharmacological target for animal aging, together with the high degree of evolutionary conservation of the pathway, suggests that inhibition of Ras-Erk-ETS signaling may provide an effective target for anti-aging interventions in mammals. Video Abstract

UR - http://www.scopus.com/inward/record.url?scp=84934434966&partnerID=8YFLogxK

U2 - 10.1016/j.cell.2015.06.023

DO - 10.1016/j.cell.2015.06.023

M3 - Article

VL - 162

SP - 72

EP - 83

JO - Cell

T2 - Cell

JF - Cell

SN - 0092-8674

IS - 1

ER -

Slack C, Alic N, Foley A, Cabecinha M, Hoddinott MP, Partridge L. The Ras-Erk-ETS-signaling pathway is a drug target for longevity. Cell. 2015 Jul 2;162(1):72-83. https://doi.org/10.1016/j.cell.2015.06.023